ORIGINAL RESEARCH
Accepted on 22 Sep 2025
Development of CRISPR/Cas9-mediated CD16b-/- and CD32a-/- promyelocytic cell lines to study FcgR signaling in human neutrophils
doi 10.3389/fimmu.2025.1633609
- 291 views
3,161
Total downloads
14k
Total views and downloads
ORIGINAL RESEARCH
Accepted on 22 Sep 2025
ORIGINAL RESEARCH
Published on 18 Jun 2025
REVIEW
Published on 16 May 2025
REVIEW
Published on 10 Dec 2024
ORIGINAL RESEARCH
Published on 20 Jun 2024